According to a recent FMI analysis, the size of the global alcohol use disorder treatment market is expected to grow at a 6.4% CAGR between 2023 and 2033. By the end of the evaluation period, the market is expected to be worth US$ 1300 million. The treatment of alcohol use disorder is growing due to rising drug awareness campaigns, preventative measures, and technological developments.
Several countries have seen an increase in patient awareness, an increase in treatment-seeking frequency, increased government participation, and a greater emphasis on addiction prevention as a result of drug awareness campaigns and accompanying preventative programmes. To communicate knowledge, television advertising, newspapers, information pamphlets, and other forms of media are used, all of which aid in market expansion. As The number of people effectively treated for AUD is increasing as a result of new drugs that prevent deterioration while also managing alcohol urges.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-16418
Each year, over 30,000 people die in the United States as a result of liver cirrhosis, the vast majority of which are caused by alcohol consumption. North America dominates the market for AUD treatment due to the availability of treatment drugs and a well-developed health infrastructure. Since India and China are the world’s two most populous countries, Asia Pacific has the highest population density. The Asia-Pacific region is expected to grow at a high rate from 2023 to 2033, owing to an increase in vulnerable adult population and increased demand for AUD treatment.
Key Takeaways from the Market Study
- According to FMI, the worldwide Alcohol Use Disorder Treatment market would grow at a 6.4% value CAGR by 2033.
- The global Alcohol Use Disorder Treatment market is expected to be worth US$ 700 million.
- The global Alcohol Use Disorder Treatment market is anticipated to be worth US$ 1,300 million.
- Europe is expected to be the most profitable region for Alcohol Use Disorder Treatment market growth.
- North America is predicted to increase at a CAGR of 6.2% between 2023 and 2033.
- According to Future Market Insights, Asia Pacific is predicted to develop at a CAGR of 6% from 2023 to 2033.
- The alcohol abuse segment is expected to hold the largest market share for Alcohol Use Disorder Treatment in the forecast period 2023 to 2033.
“Drug awareness programmes and addiction & recovery facilities among the people are considerably contributing to market growth. One of the most important aspects of the development of the Alcohol Use Disorder Treatment industry is the use of awareness campaigns and associated anticipatory programmes,” says an analyst at FMI.
Unleash Potential: Craft Your Customized Report Now:
https://www.futuremarketinsights.com/customization-available/rep-gb-16418
Market Competition
Prominent players in the Alcohol Use Disorder Treatment market are Alkermes, Teva Pharmaceutical Industries Ltd., BioCorRx, Inc., Adial Pharmaceuticals, ADDEX THERAPEUTICS, Kinnov Therapeutics, Opiant Pharmaceuticals, Omeros Corporation, GlaxoSmithKline plc and Merck & Co. Inc.
- BioCorRx Inc., a developer and provider of innovative treatment programmes for substance abuse and related disorders, announced a partnership with Government Plus LLC, a leading provider of private sector healthcare to veterans, in December 2022, to expand its Beat Addiction Recovery Programme across the country.
- Opiant Pharmaceuticals Inc. announced in November 2022 that it has agreed into a final merger agreement with Indivior Inc, a subsidiary of Indivior PLC, to be acquired. Indivior will buy all of Opiant’s existing shares for $20.00 per share in cash at closing, plus contingent value rights (CVRs) reflecting potential further payments of up to $8.00 per share over a seven-year period if the acquisition is completed.
More Valuable Insights Available
Future Market Insights offers an unbiased analysis of the global Alcohol Use Disorder Treatment market, providing historical data for 2018 to 2022 and forecast statistics from 2023 to 2033.
Key Segments:
By Disorder Type:
- Alcohol Abuse
- Alcohol Dependence
- Alcohol Addiction
- Alcoholism
By Treatment Type:
- Medication
- Therapy
- Multidisciplinary Treatment
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
